Cargando…
Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
Autores principales: | Angeletti, Andrea, Bruschi, Maurizio, Colucci, Manuela, Kajana, Xhuliana, La Porta, Edoardo, Caridi, Gianluca, Lugani, Francesca, Ravani, Pietro, Vivarelli, Marina, Cravedi, Paolo, Ghiggeri, Gian Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751525/ https://www.ncbi.nlm.nih.gov/pubmed/36531872 http://dx.doi.org/10.1016/j.ekir.2022.08.006 |
Ejemplares similares
-
Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021) -
Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment
por: Angeletti, Andrea, et al.
Publicado: (2023) -
Vaccines and nephrotic syndrome: efficacy and safety
por: Angeletti, Andrea, et al.
Publicado: (2022) -
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017) -
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children
por: Trincianti, Chiara, et al.
Publicado: (2022)